abstract |
The present invention provides a method for enhancing the antitumor effect of tegafur and reducing gastrointestinal toxicity. The method comprises administering to a patient under fasting conditions a composition comprising tegafur, a DPD inhibitor and oxonic acid or a pharmaceutically acceptable salt thereof. |